ARCHIVES

New Breast Cancer Therapies Move Into General Practice; Fisher, Miami Plan Segmental Trials

This article is from The Cancer Letter archive.

Vol. 02 No. 07 | February 13, 1976

Download PDF Visit The Full Archive

Related Articles

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

May 12, 2000

Scientists Glimpse Cellular Machines Inside Living Cells; Funding Opportunities

November 22, 2002

Proteomics Used To Find Predictor Of Response In FAP

April 30, 2004

DCE Board Approves Support Contract Recompetition

July 6, 1990

Skipper’s Impact: Drugs Curing 40,000 a Year

March 27, 1981

DCE Board Approves Concept For New $850,000 Year Grant Program To Study Viruses In Cervical Cancer

November 9, 1984